Skip to main content

Advertisement

Log in

Differences of Onset Age and Survival Rates in Esophageal Squamous Cell Carcinoma Cases with and without Family History of Upper Gastrointestinal Cancer from a High-incidence Area in North China

  • Original Paper
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Background

Gene expression analyses indicate that there are 152 genes of which the expression differs significantly in esophageal squamous cell carcinoma (ESCC) cases with positive as opposed to those with negative family history of upper gastrointestinal cancer (FHUGIC) in the high-incidence area for ESCC in northern China. However, the question as to whether there is any difference of onset age or survival rates in the familial and sporadic cases of ESCC in the area is unknown.

Aims

To investigate the differences of onset age or survival rates in the familial and sporadic cases of ESCC for surgically treated ESCC patients from the high-incidence area.

Methods

Retrospective analyses were performed on the clinicopathologic and survival data of ESCC cases (N = 1715) who had undergone surgery alone from 1985 to 1994 in Hebei Cancer Center, a provincial cancer center established primarily to treat esophageal cancer in the high-incidence area, to investigate the differences. All the patients had been native residents of the high-incidence area in northern China. Student’s t-test was used to test the difference of onset ages, and Cox Proportional Hazard Model was used to examine the differences of survival rates in the familial and sporadic cases of ESCC.

Results

Although the familial cases of ESCC had had a significantly earlier onset than the sporadic cases (P < 0.00), they experienced relatively lower survival rates than the sporadic cases after surgery. The differences of survival rates in the familial and sporadic cases were significant for patients above the age of 50 years (P Wald = 0.04) and for the Tis, 1 N0M0 group (P Wald = 0.04), the differences were bigger for early-staged than for the later-stage groups, and the differences persisted when adjusted for or stratified by confounding factors such as sex, age (under versus above the age of 50 years), smoking, drinking, cancer segment location, surgery year (calendar year), stage (UICC 4th Ed, 1987), and Resection category. Overall, cases under the age of 50 years old showed a higher survival curve than cases above the age of 50 years old, and this was especially true for the familial case group where the difference was significant (P Wald = 0.03).

Conclusion

The findings suggest that the familial ESCC may develop earlier, and may have a poorer prognosis than the sporadic ESCC. Both earlier onset and poorer outcome may be important features for the familial as opposed to the sporadic cases of ESCC. The association between younger onset age and higher survival rates found for the familial cases may indicate some survival benefit for early discovery for people with positive FHUGIC in the high-incidence area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ESCC:

Esophageal squamous cell carcinoma

FHUGIC:

Family history of upper gastrointestinal cancer

References

  1. Wu YK, Loucks HH (1951) Carcinoma of the esophagus or cardia of the stomach. Ann Surg 131:946–956

    Article  Google Scholar 

  2. Chang-Claude J, Becher H, Blettner M, et al (1997) Familial aggregation of esophagus cancer in a higher incidence area in China. Int J Epidemilol 26:1159–1165

    Article  CAS  Google Scholar 

  3. Hu N, Dawsey SM, Wu M, et al (1992) Familial aggregation of ESCC in Yangcheng County, Shanxi Province, China. Int J Epidemiol 21:877–882

    PubMed  CAS  Google Scholar 

  4. Hua S, Nan H, Joanna S, et al (2003) Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 63:3872–3876

    PubMed  Google Scholar 

  5. Hu YC, Lam KY, Law S (2001) Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC. Clin Cancer Res 7:3519–3525

    PubMed  CAS  Google Scholar 

  6. Hu YC, Lam KY, Law S, et al (2001) Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 7:2213–2221

    PubMed  CAS  Google Scholar 

  7. Takeuchi H, Ozawa S, Shih CH, et al (2004) Loss of p16INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus. Int J Cancer 109:483–490

    Article  PubMed  CAS  Google Scholar 

  8. Tong T, Zhong Y, Kong J, et al (2004) Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin Cancer Res 10:7304–7310

    Article  PubMed  CAS  Google Scholar 

  9. Ito T, Shimada Y, Hashimoto Y, et al (2003) Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res 63:6320–6626

    PubMed  CAS  Google Scholar 

  10. Kuo KT, Chow KC, Wu YC, et al (2003) Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma. Ann Thorac Surg 76:909–914

    Article  PubMed  Google Scholar 

  11. Miyazaki T, Kato H, Shitara Y, et al (2000) Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer 89:955–962

    Article  PubMed  CAS  Google Scholar 

  12. Miyazaki T, Kato H, Nakajima M, et al (2003) FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 89:140–145

    Article  PubMed  CAS  Google Scholar 

  13. Takeuchi H, Ozawa S, Shih CH, et al (2004) Loss of p16INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus. Int J Cancer 109:483–490

    Article  PubMed  CAS  Google Scholar 

  14. Makoto T, Hiromasa F, Nobuyuki A, et al (2004) Mina53 as a potential prognostic factor for esophageal squamous cell carcinoma. Clin Cancer Res 10:7347–7356

    Article  PubMed  Google Scholar 

  15. Miyazaki T, Kato H, Fukuchi M, et al (2003) EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer 103:657–663

    Article  PubMed  CAS  Google Scholar 

  16. Wang LS, Chow KC, Lien YC, et al (2004) Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma. Eur J Cardiothorac Surg 26:419–424

    Article  PubMed  CAS  Google Scholar 

  17. Hsia JY, Chen CY, Chen JT, et al (2003) Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma. Eur J Surg Oncol 29:44–48

    Article  PubMed  Google Scholar 

  18. Takeno S, Noguchi T, Kikuchi R (2002) Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 94:2874–2481

    Article  PubMed  CAS  Google Scholar 

  19. Yamamoto S, Tomita Y, Hoshida Y, et al (2004) Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin Cancer Res 15:5558–5565

    Article  Google Scholar 

  20. Iizuka N, Tangoku A, Hayashi H, et al (1999) The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma. Cancer Lett 26:139–144

    Article  Google Scholar 

  21. Wang DY, Xiang YY, Tanaka M, et al (1994) High prevalence of p53 protein overexpression in patients with ESCC in Linxian, China and its relationship to progression and prognosis. Cancer 74:3089–3096

    Article  PubMed  CAS  Google Scholar 

  22. Ikeguchi M, Maeta M, Kaibara N (2001) Bax expression as a prognostic marker of postoperative chemotherapy for patients with ESCC. Int J Mol Med 7:413–417

    PubMed  CAS  Google Scholar 

  23. Kishi K, Doki Y, Yano M, et al (2003) Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in ESCCs. Clin Cancer Res 9:4368–4375

    PubMed  CAS  Google Scholar 

  24. Shimada Y, Hashimoto Y, Kan T, et al (2004) Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma. Oncology 67:73–80

    Article  PubMed  CAS  Google Scholar 

  25. Faried A, Sohada M, Nakajima M, et al (2004) Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Eur J Cancer 40:2804–2811

    Article  PubMed  CAS  Google Scholar 

  26. Kimura Y, Watanabe M, Ohga T, et al (2003) Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma. Oncol Rep 10:1747–1751

    PubMed  Google Scholar 

  27. Jun H, Yutong H, Cuiyun Q, et al (2002) Incidence rates of oesophagus and stomach cancer in Cixian, China from 1993 to 1997. In: Parkin DM, Whelan SL, Ferlay J, et al (eds) Cancer incidence in five continents, vol VIII. International Agency for Research on Cancer (IARC) Scientific Publications No.155, Lyon, France, p 217

  28. Denggui W, Jun H, Zhongshu L, et al (2004) Preliminary results of cancer registry in Shexian County from 2000 to 2002. In: 26th annual meeting of the International Association of Cancer Registries. Beijing, China, p 92

  29. SPSS Incorporation (1999) SPSS 10.0 for the windows. SPSS Inc, Chicago (IL)

    Google Scholar 

  30. Hu N, Roth MJ, Emmert-Buck MR, Tang ZZ Polymeropolous M Wang QH, et al (1999) Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer. Clin Cancer Res 5:476–482

    Google Scholar 

  31. Yakshe PN, Fleischer DE (1992) Neoplasms of the esophagus. In: DO Castell (ed) The esophagus. Little Brown and Company, Boston (MA), pp 281–282

    Google Scholar 

  32. Axon PR, Simo R, Fergie N, Temple RH (2000) Carcinoma of the hypopharynx and cervical esophagus in young age at diagnosis. Ann Otol Rhinol Laryngol 109:590–593

    PubMed  CAS  Google Scholar 

  33. Wang HW, Kuo KT, Wu YC, et al (2004) Surgical results of upper thoracic esophageal carcinoma. J Chin Med Assoc 67:447–457

    PubMed  Google Scholar 

Download references

Acknowledgements

They authors are grateful to colleagues in the Departments of Thoracic Surgery, Anesthesia, and Surgical Operation at The Fourth Hospital of Hebei Medical University for their great contribution to surgical treatment of esophageal cancer.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shijie Wang.

Additional information

This work was partially supported by Grants from Hebei Provincial Natural Scientific Foundation (No. C2005000797), from Hebei Scientific Research (032761100D-1), and from the Key Project of Hebei Province (No.03276198D)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wen, D., Wang, S., Zhang, L. et al. Differences of Onset Age and Survival Rates in Esophageal Squamous Cell Carcinoma Cases with and without Family History of Upper Gastrointestinal Cancer from a High-incidence Area in North China. Familial Cancer 5, 343–352 (2006). https://doi.org/10.1007/s10689-006-0004-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-006-0004-x

Key words

Navigation